| Name | 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfinyl-1H-benzimidazole |
|---|---|
| Synonyms |
Tcbz-SX
Triclabendazole sulfoxide 1H-Benzimidazole,6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfinyl) 5-chloro-6-(2,3-dichlorophenoxy)-2-methylsulfinyl-1H-benzimidazole triclabendazole sulphoxide |
| Description | Triclabendazole sulfoxide (TCBZ-SO) is the main plasma metabolite of Triclabendazole, and exhibits anti-parasite effects. Triclabendazole sulfoxide can inhibit membrane transporter ABCG2/BCRP[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.69 |
|---|---|
| Boiling Point | 547.6ºC at 760 mmHg |
| Molecular Formula | C14H9Cl3N2O2S |
| Molecular Weight | 375.65700 |
| Flash Point | 285ºC |
| Exact Mass | 373.94500 |
| PSA | 74.19000 |
| LogP | 5.91850 |
| Vapour Pressure | 4.81E-12mmHg at 25°C |
| Index of Refraction | 1.749 |
| Storage condition | 2-8°C |
|
~93%
100648-13-3 |
| Literature: Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), , # 22 p. 3129 - 3134 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |